Polimerbio key facts
as of Oct 2026- Developer of polymer-based medical devices designed to replace non-biodegradable devices and improve soft tissue regeneration.
- Polimerbio is valued at approximately $6.4M as of Oct 2026 (last reported valuation).
- It has raised $3.5M; the latest was Later Stage VC ($1.1M) in Dec 2025.
- Notable investors include Clave (Pamplona), CDTI Innvierte, BIC Araba, Caja de Ahorros y Monte de Piedad de Gipuzkoa y San Sebastián, Ekin + Program — 10 tracked in total.
- Status: Privately Held (backing).
Polimerbio's last reported valuation, Dec 2025. Nothing priced has surfaced since.
- ·Watch Polimerbio: the Monday email on marks, rounds and moves
Polimerbio funding rounds
No funding rounds for Polimerbio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Polimerbio valuation
Polimerbio's last reported valuation was $6.4 million in Dec 2025. No priced round, secondary trade or fund mark has surfaced since.
Polimerbio investors
10 investors are on record for Polimerbio, including Clave (Pamplona), CDTI Innvierte, BIC Araba and Caja de Ahorros y Monte de Piedad de Gipuzkoa y San Sebastián.
About Polimerbio
Developer of polymer-based medical devices designed to replace non-biodegradable devices and improve soft tissue regeneration. The company's devices are created by using new materials for biomedical devices and tissue engineering, enabling medical professionals to reduce surgical interventions and hospital costs and improve patients' quality of life.
- Sector
- Healthcare
- HQ
- Donostia-San Sebastian, Spain
- Founded
- 2017
- Employees
- 13
- Website
- polimerbio.com/
- Ownership
- Privately Held (backing)
Is this your company? Profiles are maintained at PrivateMarketView, the data platform behind this page — sign in with your work email to keep it current, or tell us what's wrong.